Fabrice Carrat
#136,467
Most Influential Person Now
Researcher
Fabrice Carrat's AcademicInfluence.com Rankings
Fabrice Carratcomputer-science Degrees
Computer Science
#6288
World Rank
#6632
Historical Rank
Computational Linguistics
#1051
World Rank
#1065
Historical Rank
Machine Learning
#1991
World Rank
#2017
Historical Rank
Artificial Intelligence
#2240
World Rank
#2278
Historical Rank
Fabrice Carratmathematics Degrees
Mathematics
#6492
World Rank
#8976
Historical Rank
Measure Theory
#1384
World Rank
#1736
Historical Rank
Download Badge
Computer Science Mathematics
Fabrice Carrat's Degrees
- PhD Computer Science Université Paris Cité
- Masters Computer Science Université Paris Cité
- Bachelors Mathematics Université Paris Cité
Similar Degrees You Can Earn
Why Is Fabrice Carrat Influential?
(Suggest an Edit or Addition)Fabrice Carrat's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Time lines of infection and disease in human influenza: a review of volunteer challenge studies. (2008) (1064)
- Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. (2004) (863)
- Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study (2009) (822)
- Influenza vaccine: the challenge of antigenic drift. (2007) (686)
- Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. (2011) (670)
- Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. (2011) (450)
- Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890. (2013) (449)
- A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data (2004) (393)
- The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. (2005) (368)
- Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases. (2018) (364)
- Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease (2017) (355)
- Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study (2019) (343)
- Risk factors of influenza transmission in households. (2004) (340)
- Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. (2013) (298)
- Liver biopsy: the best, not the gold standard. (2009) (298)
- The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis (2000) (275)
- Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis. (2014) (272)
- Noninvasive elastography‐based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis (2012) (270)
- Effect of Influenza Vaccination of Nursing Home Staff on Mortality of Residents: A Cluster‐Randomized Trial (2009) (245)
- Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure (2015) (241)
- Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis. (2014) (213)
- Monitoring epidemiologic surveillance data using hidden Markov models. (1999) (192)
- Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS. (2012) (188)
- Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy (2010) (184)
- Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey. (2012) (177)
- Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial. (2011) (170)
- Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study (2009) (165)
- Epidemiologic Mapping using the “Kriging” Method: Application to an Influenza-like Epidemic in France (1992) (158)
- Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995-1996 epidemic in France. (1999) (155)
- Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients. (2002) (154)
- A 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemics (2006) (143)
- Influenza Epidemics in the United States, France, and Australia, 1972–1997 (2004) (140)
- Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection. (2016) (140)
- INFLUENZA BURDEN OF ILLNESS: ESTIMATES FROM A NATIONAL PROSPECTIVE SURVEY OF HOUSEHOLD CONTACTS IN FRANCE (2002) (139)
- Prediction of the spread of influenza epidemics by the method of analogues. (2003) (136)
- How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited. (2008) (133)
- Mortality burden of the 1918–1919 influenza pandemic in Europe (2009) (132)
- Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic. (2021) (127)
- Transmissibility and geographic spread of the 1889 influenza pandemic (2010) (123)
- Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer (2013) (119)
- A case–control study of risk factors for hepatitis C infection in patients with unexplained routes of infection * (2006) (119)
- Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV (2006) (115)
- Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic (2010) (115)
- Surgical Mask to Prevent Influenza Transmission in Households: A Cluster Randomized Trial (2010) (115)
- Severe accidental hypothermia treated in an ICU: prognosis and outcome. (2001) (114)
- Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study). (2017) (114)
- Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study (2016) (106)
- Epidemiologic mapping using the "kriging" method: application to an influenza-like illness epidemic in France. (1992) (105)
- Risk Factors for Symptomatic Mitochondrial Toxicity in HIV/Hepatitis C Virus-Coinfected Patients During Interferon Plus Ribavirin-Based Therapy (2005) (103)
- Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients. (2017) (100)
- Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02. (2008) (99)
- Population Modeling of Influenza A/H1N1 Virus Kinetics and Symptom Dynamics (2010) (98)
- Radiologic course of primary sclerosing cholangitis: Assessment by three‐dimensional magnetic resonance cholangiography and predictive features of progression (2014) (98)
- Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis. (2011) (98)
- Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role? (2007) (94)
- 8 SAFETY OF TELAPREVIR OR BOCEPREVIR IN COMBINATION WITH PEGINTERFERON ALFA/RIBAVIRIN, IN CIRRHOTIC NON RESPONDERS. FIRST RESULTS OF THE FRENCH EARLY ACCESS PROGRAM (ANRS CO20-CUPIC) (2012) (93)
- Hepatic steatosis in HIV–HCV coinfected patients: analysis of risk factors (2006) (93)
- Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease (2012) (93)
- Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B‐cell non‐Hodgkin lymphomas, ANRS HC‐13 lympho‐C study (2015) (93)
- Oral contraceptive use and the clinical course of Crohn’s disease: a prospective cohort study (1999) (90)
- Increased risk of acute myeloid leukemias and myelodysplastic syndromes in patients who received thiopurine treatment for inflammatory bowel disease. (2014) (87)
- Large‐scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis (2017) (83)
- Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study (2017) (82)
- Phenotypes and survival in Erdheim‐Chester disease: Results from a 165‐patient cohort (2018) (79)
- Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open- (2017) (79)
- Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections. (2006) (78)
- Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France (2021) (75)
- Mortality Burden of the 2009 A/H1N1 Influenza Pandemic in France: Comparison to Seasonal Influenza and the A/H3N2 Pandemic (2012) (75)
- The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model. (2007) (75)
- Influenza mortality among the elderly in France, 1980-90: how many deaths may have been avoided through vaccination? (1995) (73)
- Online detection and quantification of epidemics (2007) (73)
- Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients * (2021) (71)
- Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso. (2010) (71)
- Seroprevalence of SARS-CoV-2 among adults in three regions of France following the lockdown and associated risk factors: a multicohort study. (2020) (71)
- Broad respiratory virus detection in infants hospitalized for bronchiolitis by use of a multiplex RT‐PCR DNA microarray system† (2012) (69)
- Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France (2021) (68)
- High Risk of Anal and Rectal Cancer in Patients With Anal and/or Perianal Crohn’s Disease (2017) (68)
- Surveillance of influenza-like illness in France. The example of the 1995/1996 epidemic. (1998) (67)
- Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort, France. (2013) (66)
- Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors. (2008) (64)
- Incidence, Presentation, and Prognosis of Small Bowel Adenocarcinoma in Patients with Small Bowel Crohn's Disease: A Prospective Observational Study (2013) (62)
- Impact of Different Oseltamivir Regimens on Treating Influenza A Virus Infection and Resistance Emergence: Insights from a Modelling Study (2014) (61)
- The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease (2014) (61)
- Estimating influenza latency and infectious period durations using viral excretion data. (2012) (59)
- The negative impact of HBV/HCV coinfection on cirrhosis and its consequences (2017) (59)
- Explaining rapid reinfections in multiple-wave influenza outbreaks: Tristan da Cunha 1971 epidemic as a case study (2011) (58)
- Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort (2011) (57)
- Simultaneous Human Immunodeficiency Virus-Hepatitis B-Hepatitis C Point-of-Care Tests Improve Outcomes in Linkage-to-Care: Results of a Randomized Control Trial in Persons Without Healthcare Coverage (2015) (57)
- Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY) (2007) (57)
- Evaluation of Four Commercial Multiplex Molecular Tests for the Diagnosis of Acute Respiratory Infections (2015) (56)
- An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: the Liver-FibroSTARD standards. (2015) (56)
- Effect of indinavir on HIV‐related wasting (1998) (55)
- Factors associated with poor outcomes among adults hospitalized for influenza in France: A three-year prospective multicenter study. (2016) (54)
- Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement (2017) (53)
- Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France (2016) (52)
- Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France (2016) (52)
- Association Between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID‐19: An Observational Multicenter Study (2021) (51)
- Rapid and early virological response to chronic hepatitis C treatment with IFN α2b or PEG-IFN α2b plus ribavirin in HIV/HCV co-infected patients (2007) (50)
- Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: the EPIB 2008 study. (2010) (49)
- Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts (2020) (49)
- Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study. (2017) (49)
- A Sero-epidemiological Study of Arboviral Fevers in Djibouti, Horn of Africa (2014) (49)
- Influenza C virus high seroprevalence rates observed in 3 different population groups. (2014) (48)
- Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey (2012) (48)
- Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment. (2005) (48)
- Chronic hepatitis C virus infection: Does it really impact health‐related quality of life? A study in rural Egypt (2004) (48)
- Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based “CONSTANCES” cohort (2021) (48)
- LP05 : Daclatasvir plus sofosbuvir with or without ribavirin in patients with HCV genotype 3 infection: Interim analysis of a french multicenter compassionate use program (2015) (48)
- Exposures associated with SARS-CoV-2 infection in France: A nationwide online case-control study (2021) (48)
- Cost Effectiveness of Fibrosis Assessment Prior to Treatment for Chronic Hepatitis C Patients (2011) (47)
- Pandemic Influenza Due to pH1N1/2009 Virus: Estimation of Infection Burden in Reunion Island through a Prospective Serosurvey, Austral Winter 2009 (2011) (46)
- Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection. (2010) (45)
- Applications of Extreme Value Theory in Public Health (2016) (44)
- Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial. (2015) (44)
- Monitoring the proportion of the population infected by SARS-CoV-2 using age-stratified hospitalisation and serological data: a modelling study (2021) (42)
- Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV‐genotype 4 in Egypt (2015) (42)
- Detection of lung cancer on radiographs: receiver operating characteristic analyses of radiologists', pulmonologists', and anesthesiologists' performance. (2004) (42)
- When lockdown policies amplify social inequalities in COVID-19 infections: evidence from a cross-sectional population-based survey in France (2020) (40)
- 818 Excess Risk of Lymphoproliferative Disorders (LPD) in Inflammatory Bowel Diseases (IBD): Interim Results of the Cesame Cohort (2008) (40)
- When lockdown policies amplify social inequalities in COVID-19 infections: evidence from a cross-sectional population-based survey in France (2020) (40)
- Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study (2021) (40)
- Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study. (2015) (39)
- A scale of methodological quality for clinical studies of radiologic examinations. (2000) (39)
- Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono‐infected compared with HIV–HCV co‐infected patients (2009) (38)
- Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN. (2016) (38)
- 60 SVR12 RATES AND SAFETY OF TRIPLE THERAPY INCLUDING TELAPREVIR OR BOCEPREVIR IN 221 CIRRHOTIC NON RESPONDERS TREATED IN THE FRENCH EARLY ACCESS PROGRAM (ANRS CO20-CUPIC) (2013) (38)
- LO3 : Safety and efficacy of the combination daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients from the french observational cohort ANRS CO22 hepather* (2015) (38)
- Comparison of a new method for the direct and simultaneous assessment of LDL- and HDL-cholesterol with ultracentrifugation and established methods. (2000) (38)
- Risk of Melanoma in Patients Who Receive Thiopurines for Inflammatory Bowel Disease Is Not Increased (2012) (36)
- Intense Co-Circulation of Non-Influenza Respiratory Viruses during the First Wave of Pandemic Influenza pH1N1/2009: A Cohort Study in Reunion Island (2012) (36)
- Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status. (2020) (36)
- Repeated influenza vaccination of healthy children and adults: borrow now, pay later? (2005) (35)
- Ischemic stroke in giant-cell arteritis: French retrospective study. (2019) (35)
- Assessment and determinants of aesthetic discomfort in hand osteoarthritis (2011) (34)
- A virologic survey of patients admitted to a critical care unit for acute cardiorespiratory failure (2005) (34)
- Epidemiology of idiopathic nephrotic syndrome in children: endemic or epidemic? (2016) (33)
- Detection of independent associations in a large epidemiologic dataset: a comparison of random forests, boosted regression trees, conventional and penalized logistic regression for identifying independent factors associated with H1N1pdm influenza infections (2014) (33)
- Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study (2019) (33)
- Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis. (2020) (32)
- The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease (2017) (32)
- Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV–hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 Study (2009) (32)
- Daclatasvir plus sofosbuvir with or without ribavirin in genotype 3 patients from a large French multicenter compassionate use program (2015) (32)
- Field Effectiveness of Pandemic and 2009-2010 Seasonal Vaccines against 2009-2010 A(H1N1) Influenza: Estimations from Surveillance Data in France (2011) (31)
- Burden of infections among 44,869 elderly in nursing homes: a cross-sectional cluster nationwide survey. (2011) (31)
- Multiplex PCR performed of bronchoalveolar lavage fluid increases pathogen identification rate in critically ill patients with pneumonia: a pilot study (2014) (31)
- Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial. (2016) (31)
- External validation of prognostic scores for COVID-19: a multicenter cohort study of patients hospitalized in Greater Paris University Hospitals (2021) (31)
- Early estimates of 2009 pandemic influenza A(H1N1) virus activity in general practice in France: incidence of influenza-like illness and age distribution of reported cases. (2009) (31)
- LP28 : Efficacy of the oral sofosbuvir-based combinations in HCV genotype 4-mono-infected patients from the french observational cohort anrs CO22 hepather (2015) (30)
- Influenza and influenza-like illness in general practice: drawing lessons for surveillance from a pilot study in Paris, France. (1997) (30)
- Detailed analysis of the genetic evolution of influenza virus during the course of an epidemic (2005) (30)
- Risk of hepatitis C virus transmission to surgeons and nurses from infected patients: model-based estimates in France. (1999) (30)
- Effect of Oseltamivir, Zanamivir or Oseltamivir– Zanamivir Combination Treatments on Transmission of Influenza in Households (2012) (30)
- Predicting Pneumonia and Influenza Mortality from Morbidity Data (2007) (30)
- A short-term, multicomponent infection control program in nursing homes: a cluster randomized controlled trial. (2012) (29)
- Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination. (2003) (29)
- Exploring cross-protection between influenza strains by an epidemiological model. (2004) (29)
- Incidence and risk factors of COVID-19-like symptoms in the French general population during the lockdown period: a multi-cohort study (2021) (28)
- Morbidity and mortality associated with influenza exposure in long-term care facilities for dependant elderly people (2009) (28)
- Trends in influenza vaccination behaviours--results from the CoPanFlu cohort, France, 2006 to 2011. (2013) (28)
- Incidence and risk factors of COVID-19-like symptoms in the French general population during the lockdown period: a multi-cohort study (2021) (28)
- Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult population (2020) (28)
- Characterization of pandemic influenza immune memory signature after vaccination or infection. (2014) (28)
- Factors of weight loss in patients with HIV and chronic diarrhea. (1998) (28)
- Effect of Antiviral Treatment on Serum Markers of Liver Fibrosis in HIV–Hepatitis C virus-Coinfected Patients: The Fibrovic 2 Study – ANRS HC02 (2008) (28)
- Air pollution and respiratory drug sales in the City of Le Havre, France, 1993-1996. (1999) (28)
- Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult‐to‐treat primary biliary cholangitis (2021) (27)
- 281 Thiopurine Therapy Is Associated with a Three-Fold Decrease in the Incidence of Advanced Colorectal Neoplasia in IBD Patients with Longstanding Extensive Colitis: Results from the CESAME Cohort (2009) (27)
- Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patients. (2017) (26)
- Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Study. (2016) (25)
- Field investigation of influenza vaccine effectiveness on morbidity. (1998) (25)
- Biased and unbiased estimation of the average length of stay in intensive care units in the Covid-19 pandemic (2020) (25)
- Risk factors for anaemia in human immunodeficiency virus/hepatitis C virus‐coinfected patients treated with interferon plus ribavirin (2007) (25)
- Factors Associated with Post-Seasonal Serological Titer and Risk Factors for Infection with the Pandemic A/H1N1 Virus in the French General Population (2013) (24)
- Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis. (2021) (24)
- Nationwide surveillance of 18 respiratory viruses in patients with influenza‐like illnesses: A pilot feasibility study in the French Sentinel Network (2011) (23)
- Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus. (2011) (23)
- Guidelines for infection control in nursing homes: a Delphi consensus web-based survey. (2011) (22)
- High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART? (2007) (22)
- Statin and aspirin for prevention of hepatocellular carcinoma: what are the levels of evidence? (2014) (22)
- The influenza A (H1N1) pandemic in Reunion Island: knowledge, perceived risk and precautionary behaviour (2013) (22)
- Rapid and early virological response to chronic hepatitis C treatment with IFN alpha2b or PEG-IFN alpha2b plus ribavirin in HIV/HCV co-infected patients. (2007) (22)
- Simultaneous investigation of influenza and enteric viruses in the stools of adult patients consulting in general practice for acute diarrhea (2012) (22)
- Longitudinal and Integrative Biomodeling of Effector and Memory Immune Compartments after Inactivated Influenza Vaccination (2013) (21)
- Severe weight loss in HIV / HCV‐coinfected patients treated with interferon plus ribavirin: incidence and risk factors (2008) (21)
- Early Detection and Assessment of Epidemics by Particle Filtering (2008) (21)
- Diagnosis Scoring for Clinical Identification of Children With Heterozygous Familial Hypercholesterolemia (2009) (20)
- A systematic review on the effect of the organisation of hospital discharge on patient health outcomes (2016) (20)
- Non-influenza respiratory viruses in adult patients admitted with influenza-like illness: a 3-year prospective multicenter study (2020) (20)
- Clinical validation of IFNγ/IL-10 and IFNγ/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humans (2014) (20)
- Hepatitis E Virus Infection in Sheltered Homeless Persons, France (2012) (20)
- Coronary heart disease is associated with a worse clinical outcome of hand osteoarthritis: a cross-sectional and longitudinal study (2017) (20)
- Predictors of early relapse in patients with non-infectious mixed cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey. (2014) (19)
- Nutritional risk factors for SARS-CoV-2 infection: a prospective study within the NutriNet-Santé cohort (2021) (19)
- Current State of and Needs for Hepatitis B Screening: Results of a Large Screening Study in a Low-Prevalent, Metropolitan Region (2014) (19)
- Integrative study of pandemic A/H1N1 influenza infections: design and methods of the CoPanFlu-France cohort (2012) (19)
- Representations of influenza and influenza-like illness in the community - a qualitative study (2013) (19)
- Nutritional risk factors for SARS-CoV-2 infection: a prospective study within the NutriNet-Santé cohort (2021) (19)
- Inflammatory disorders associated with trisomy 8‐myelodysplastic syndromes: French retrospective case‐control study (2018) (18)
- Randomised active programs on healthcareworkers’ flu vaccination in geriatric health care settings in France: The VESTA study (2010) (18)
- Gastrointestinal Behcet’s-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature review (2018) (18)
- Women Experience Higher Rates of Adverse Events During Hepatitis C Virus Therapy in HIV Infection: A Meta-Analysis (2010) (18)
- Autoimmune manifestations associated with lymphoma: characteristics and outcome in a multicenter retrospective cohort study (2018) (17)
- Age distribution of cases and deaths during the 1889 influenza pandemic. (2011) (17)
- Risk factors of pandemic influenza A/H1N1 in a prospective household cohort in the general population: results from the CoPanFlu-France cohort (2014) (17)
- Impact on Life Expectancy of Withdrawing Thiopurines in Patients with Crohn’s Disease in Sustained Clinical Remission: A Lifetime Risk-Benefit Analysis (2016) (17)
- Therapeutic management and evolution of chronic hepatitis B: does HIV still have an impact? The EPIB 2012 study (2015) (17)
- 255 Aminosalicylates, Thiopurines and the Risk of Colorectal Cancer in Inflammatory Bowel Diseases: A Case-Control Study Nested in the CESAME Cohort (2010) (17)
- Planning for the next influenza H1N1 season: a modelling study (2010) (17)
- In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas (2016) (17)
- Impact of bucco-dental healthcare on the prevention of pneumonia in geriatrics: a cluster-randomised trial. (2011) (15)
- Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy. (2008) (15)
- [Transmission modes of hepatitis C virus]. (1998) (15)
- Antibiotic Treatment for Influenza does not Affect Resolution of Illness, Secondary Visits or Lost Workdays (2003) (15)
- Contribution of Genome-Wide Association Studies to Scientific Research: A Bibliometric Survey of the Citation Impacts of GWAS and Candidate Gene Studies Published during the Same Period and in the Same Journals (2012) (15)
- Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death. (2020) (15)
- Targeted vs. systematic early antiviral treatment against A(H1N1)v influenza with neuraminidase inhibitors in patients with influenza-like symptoms: Clinical and economic impact (2009) (15)
- Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19 (2020) (15)
- A new out-patient care facility for HIV-infected destitute populations in Paris, France. (1997) (15)
- Comparison of Serum Hepatitis C Virus (HCV) RNA and Core Antigen Levels in Patients Coinfected with Human Immunodeficiency Virus and HCV and Treated with Interferon plus Ribavirin (2006) (14)
- Risk Factors for Acute Liver Enzyme Abnormalities in HIV-Hepatitis B Virus-Coinfected Patients on Antiretroviral Therapy (2007) (14)
- Population modeling of influenza A / H 1 N 1 viral kinetics and symptom dynamics (2010) (14)
- Clinical Outcomes in HCV-Infected Patients Treated with Direct Acting Antivirals - 18 Month Post-Treatment Follow-Up in the French ANRS CO22 Hepather Cohort Study (2016) (13)
- 292 EROSIVE VERSUS NON EROSIVE HAND OA: PROSPECTIVE CROSS-SECTIONAL COMPARISON OF CLINICAL DATA (2008) (13)
- Immune activation, smoking, and vaccine response (2017) (12)
- Seroprevalence of SARS-CoV-2 Among Adults in Three Regions of France Following the Lockdown and Associated Risk Factors: A Multicohort Study (2020) (12)
- Characteristics of human metapneumovirus infection in adults hospitalized for community-acquired influenza-like illness in France, 2012–2018: a retrospective observational study (2020) (12)
- Assessment of Public Health and Economic Impact of Intranasal Live-Attenuated Influenza Vaccination of Children in France Using a Dynamic Transmission Model (2017) (12)
- 2009 A(H1N1) Seroconversion Rates and Risk Factors among the General Population in Vientiane Capital, Laos (2013) (12)
- Heterogeneous shedding of influenza by human subjects and its implications for epidemiology and control (2016) (12)
- Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis. (2022) (12)
- Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S COCOPREV study) (2022) (12)
- Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature review. (2019) (12)
- O112 : HBsAg clearance after addition of 48 weeks of pegifn in HBeAg negative CHB patients on nucleos(T)ide therapy with undetectable hbvdna for at least one year: final results from ANRS-HB06 pegan study: multicenter randomized controlled phase III trial (2015) (12)
- "If you have the flu symptoms, your asymptomatic spouse may better answer the willingness-to-pay question". Evidence from a double-bounded dichotomous choice model with heterogeneous anchoring. (2009) (11)
- Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C‐infected patients (ANRS CO22 Hepather cohort) (2020) (11)
- GS-03-Global real world evidence of sofosbuvir/velpatasvir as a simple, effective regimen for the treatment of chronic hepatitis C patients: Integrated analysis of 12 clinical practice cohorts (2019) (11)
- Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study. (2014) (11)
- Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study. (2015) (11)
- Performance of the marginal structural cox model for estimating individual and joined effects of treatments given in combination (2017) (11)
- Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2 (2022) (11)
- Determinants of individuals’ risks to 2009 pandemic influenza virus infection at household level amongst Djibouti city residents - A CoPanFlu cross-sectional study (2014) (10)
- [Anti-influenza vaccine. Bibliographic review]. (1994) (10)
- Assessment of healthcare worker influenza vaccination program in French geriatric wards: a cluster-randomized controlled trial (2010) (10)
- Consequences of misdiagnosis of intrauterine growth retardation for preterm elective cesarean section. (1993) (10)
- [Effects of preoperative artificial nutrition in intestinal resections for Crohn disease]. (1996) (10)
- Management of chronic hepatitis C in French departments of internal medicine and infectious diseases (2005) (10)
- Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008-2009 winter. (2013) (10)
- Causal analysis of H1N1pdm09 influenza infection risk in a household cohort (2014) (10)
- Risk of Death in Individuals Hospitalized for COVID-19 With and Without Psychiatric Disorders: An Observational Multicenter Study in France (2022) (10)
- Gamma glutamyl transferase elevation in HIV/Hepatitis C virus-coinfected patients during interferon-ribavirin combination therapy. (2009) (10)
- The dynamic effect of direct‐acting antiviral treatments on the risk of hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis C (2019) (9)
- 7 - Thiopurine therapy is associated with a three-fold decrease in the incidence of advanced colorectal neoplasia in IBD patients with longstanding extensive colitis: the CESAME prospective data (2009) (9)
- Does nonadherence to local recommendations for empirical antibiotic therapy on admission to the intensive care unit have an impact on in-hospital mortality? (2009) (9)
- IFI35, mir-99a and HCV Genotype to Predict Sustained Virological Response to Pegylated-Interferon Plus Ribavirin in Chronic Hepatitis C (2015) (9)
- P0795 : Safety and efficacy of sofosbuvir-containing regimens in the French observational cohort ANRS CO22 HEPATHER (2015) (9)
- Effectiveness of hepatitis B rapid tests toward linkage-to-care: results of a randomized, multicenter study (2016) (9)
- Field seasonal influenza vaccine effectiveness (2013) (9)
- Using Pharmacokinetic and Viral Kinetic Modeling To Estimate the Antiviral Effectiveness of Telaprevir, Boceprevir, and Pegylated Interferon during Triple Therapy in Treatment-Experienced Hepatitis C Virus-Infected Cirrhotic Patients (2014) (8)
- Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patients. (2008) (8)
- Comparing Inpatient Satisfaction Collected via a Web-Based Questionnaire Self-Completion and Through a Telephone Interview: An Ancillary Study of the SENTIPAT Randomized Controlled Trial (2017) (8)
- Children's mental and behavioral health, schooling, and socioeconomic characteristics during school closure in France due to COVID-19: the SAPRIS project (2021) (8)
- Comparing Patients’ Opinions on the Hospital Discharge Process Collected With a Self-Reported Questionnaire Completed Via the Internet or Through a Telephone Survey: An Ancillary Study of the SENTIPAT Randomized Controlled Trial (2015) (8)
- Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis (2021) (8)
- Intensification with pegylated interferon during treatment with tenofovir in HIV–hepatitis B virus co‐infected patients (2016) (8)
- Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen - The ANRS CO20-CUPIC study. (2015) (8)
- Predictive Factors for Hepatocellular Carcinoma in Chronic Hepatitis B Using Structural Equation Modeling: A Prospective Cohort Study. (2021) (8)
- Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia: French multicenter case-control study. (2020) (7)
- No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults (2016) (7)
- Age, COVID-19-like symptoms and SARS-CoV-2 seropositivity profiles after the first wave of the pandemic in France (2021) (7)
- Reply to "A strong message is needed to address the issue of HCC recurrence after DAA therapy". (2016) (7)
- Risk perception and priority setting for intervention among hepatitis C virus and environmental risks: a cross-sectional survey in the Cairo community (2010) (7)
- Early detection of epidemic influenza (1992) (7)
- Age, COVID-19-like symptoms and SARS-CoV-2 seropositivity profiles after the first wave of the pandemic in France (2021) (7)
- Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin. (2008) (6)
- Economic evaluations of neuraminidase inhibitors to control influenza (2003) (6)
- [Cancers in systemic sclerosis : risk factors, impact on survival and literature review]. (2019) (6)
- Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study (2015) (6)
- Persistent symptoms after the first wave of COVID-19 in relation to SARS-CoV-2 serology and experience of acute symptoms: A nested survey in a population-based cohort (2022) (6)
- Persistently normal alanine aminotransferase levels in HIV/HCV‐coinfected patients: the role of steatosis (2009) (6)
- Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors‐based therapy (2015) (6)
- 622 Risk of Subsequent Cancer Under Immunosuppressive Therapy in Patients With Inflammatory Bowel Disease and Prior Cancer: Data From the CESAME Prospective Observational Cohort (2012) (6)
- Liver fibrosis: screening is not staging. (2009) (6)
- Are Posterior Oropharyngeal Saliva Specimens an Acceptable Alternative to Nasopharyngeal Sampling for the Monitoring of SARS-CoV-2 in Primary-Care Settings? (2021) (6)
- Assessment of healthcare worker influenza vaccination program in French geriatric wards: a cluster-randomized controlled trial. (2010) (6)
- Immunity against influenza A(H1N1) infections is determined by age at the time of initial strain circulation (2016) (5)
- Self-reported patient history to assess hepatitis B virus serological status during a large screening campaign (2018) (5)
- [D-Dimer determination combined with clinical probability for the diagnosis of leg venous thrombosis]. (2002) (5)
- Current management and recommendations on hepatitis B therapy in HIV-coinfected patients (2013) (5)
- Serum alpha-fetoprotein predicts virologic response to Hepatitis C treatment in HIV coinfected patients (2008) (5)
- Estimating the burden of influenza‐related and associated hospitalizations and deaths in France: An eight‐season data study, 2010–2018 (2021) (5)
- Long-lasting Symptoms After an Acute COVID-19 Infection and Factors Associated With Their Resolution (2022) (5)
- Bedside Rapid Flu Test and Zanamivir Prescription in Healthy Working Adults (2012) (5)
- Complications and factors associated with severity of influenza in hospitalized children and adults during the pandemic wave of A(H1N1)pdm2009 infections--the Fluco French cohort. (2013) (5)
- Multilabel classification of medical concepts for patient clinical profile identification (2022) (4)
- Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort (2019) (4)
- Severe transaminitis after interferon–ribavirin therapy in HIV/HCV‐coinfected patients: influence of a sustained HCV response (2012) (4)
- GS-18-Preventive administration of ursodeoxycholic acid after liver transplantation for primary biliary cholangitis prevents disease recurrence and prolongs graft survival (2019) (4)
- Cost Effectiveness of Quadrivalent Influenza Vaccine Over Trivalent Vaccine in France. (2014) (4)
- Excess Intestinal Lymphoproliferative Disorders in IBD (2011) (4)
- WTW - an algorithm for identifying "who transmits to whom" in outbreaks of interhuman transmitted infectious agents (2010) (4)
- Nationwide Seroprevalence of SARS-CoV-2 IgG Antibodies among Four Groups of Primary Health-Care Workers and Their Household Contacts 6 Months after the Initiation of the COVID-19 Vaccination Campaign in France: SeroPRIM Study Protocol (2021) (4)
- Response to Anti-HCV Therapy in HIV–HCV-Coinfected Patients: Does the Lipid Profile Really have an Effect? (2010) (4)
- Elevated coffee consumption is associated with a lower risk of elevated liver fibrosis biomarkers in patients treated for chronic hepatitis B (ANRS CO22 Hepather cohort). (2022) (4)
- Kinetics of anti-nucleocapsid IgG response in COVID-19 immunocompetent convalescent patients (2022) (4)
- Antibody persistence and serological protection among seasonal 2007 influenza A(H1N1) infected subjects: Results from the FLUREC cohort study. (2015) (4)
- Testing for hepatitis B virus alone does not increase vaccine coverage in non-immunized persons (2017) (4)
- Recommandations concernant l'utilisation des marqueurs tumoraux sériques dans la prise en charge des cancers bronchiques primitifs (1997) (4)
- Heterogeneous SARS-CoV-2 humoral response after COVID-19 vaccination and/or infection in the general population (2022) (4)
- Acute and Chronic Sarcoid Arthropathies: Characteristics and Treatments From a Retrospective Nationwide French Study (2020) (4)
- Vaccinations : actualités et perspectives (1999) (4)
- Viral pneumonia and respiratory sepsis: association, causation, or it depends? (2007) (4)
- Nutritional risk factors for SARS-CoV-2 infection: prospective study from the NutriNet-Santé cohort (2021) (4)
- Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial) (2017) (4)
- How much are patients willing to pay for an earlier alleviation of influenza (2001) (4)
- IFI 35 , mir-99 a and HCV Genotype to Predict Sustained Virological Response to Pegylated-Interferon Plus Ribavirin in Chronic Hepatitis C (2019) (4)
- Sofosbuvir‐Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real‐life experience from the HEPATHER ANRS CO22 cohort (2020) (4)
- Cannabis Use Is Inversely Associated with Overweight and Obesity in Hepatitis B Virus-Infected Patients (ANRS CO22 Hepather Cohort). (2021) (3)
- Incidence and Risk Factors of Illnesses Presumably Caused by A SARS-CoV-2 Infection in The General Population During The Lockdown Period: A Multi-Cohort Study. (2020) (3)
- External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV (2021) (3)
- Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohort. (2020) (3)
- A systematic analysis of all ICD10-coded death certificates in France, 2000, with a mention of influenza as cause of death (2004) (3)
- ' s response to reviews Title : Planning for the next influenza H 1 N 1 season : a modelling study (2010) (3)
- Prevalence of cardiovascular risk factors, the use of statins and of aspirin in Takayasu Arteritis (2021) (3)
- Comparing SF-36 Scores Collected Through Web-Based Questionnaire Self-completions and Telephone Interviews: An Ancillary Study of the SENTIPAT Multicenter Randomized Controlled Trial (2022) (3)
- Bezafibrate Add-On Therapy Improves Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis: A Japanese Nationwide Cohort Study. (2021) (3)
- Report of the 2nd "French Clinical Vaccinology Meeting Jean-Gerard Guillet": immunization and respiratory diseases. (2010) (3)
- P0468 : Negative impact of HBV/HCV coinfection on HBV or HCV monoinfection: Data from the French cohort – ANRS CO22 hepather (2015) (3)
- A Model-Based Illustrative Exploratory Approach to Optimize the Dosing of Peg-IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy (2014) (3)
- Corrigendum to: Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study (2021) (3)
- 746 The impact of ursodeoxycholic acid (UDCA) therapy with or without liver transplantation (OLT) on long-term survival in primary biliary cirrhosis (2003) (3)
- [Does Doppler analysis of hepatic venous flow predict increased right atrial pressure and right ventricular dysfunction?]. (2001) (3)
- L'impact sanitaire et économique de la grippe (2002) (3)
- Prevalence, patterns and outcomes of cardiac involvement in Erdheim-Chester disease. (2022) (3)
- Comparer deux groupes (2000) (3)
- High risk of mitochondriopathy in HIV/HCV co-infected patients under concomitant DDI/D4T and interferon (standard or pegylated IFN) /ribavirin treatments (2003) (3)
- Effect of resistance-associated substitutions on retreatment of direct acting antiviral-exposed patients in the real-world setting (ANRS CO22 HEPATHER) (2017) (3)
- Heterosubtypic immunity to influenza: right hypothesis, wrong comparison. (2006) (3)
- 141 Pregnancy Outcome in Inflammatory Bowel Disease for Women Treated with Thiopurine: Cohort from the CESAME Study (2009) (3)
- Liver-FibroSTARD checklist and glossary: tools for standardized design and reporting of diagnostic accuracy studies of liver fibrosis tests (2015) (3)
- 790 INSULIN RESISTANCE IS A SPECIFIC FEATURE OF HEPATIC FIBROSIS AND STEATOSIS IN HCV MONOINFECTED PATIENTS BUT NOT IN HIV-HCV COINFECTED PATIENTS: A CASE-CONTROL STUDY (2008) (2)
- Small Bowel Adenocarcinoma During Crohn's Disease: A Prospective Observational Cohort Study (2011) (2)
- Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort) (2021) (2)
- Seasonal burden of severe influenza virus infection in the critically ill patients, using the Assistance Publique-Hôpitaux de Paris clinical data warehouse: a pilot study (2021) (2)
- Impact of direct‐acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers (2022) (2)
- [Colonic involvement in ileal Crohn's disease]. (1998) (2)
- Risk of Squamous and Basal Cell Carcinomas in Patients With Inflammatory Bowel Disorders Exposed to Thiopurines: The CESAME National Cohort Study (2011) (2)
- Signal detection on a patient cohort: A disproportionality analysis of the ANRS CO22 HEPATHER cohort to identify associations between direct acting antivirals and adverse events in patients with hepatitis C virus chronic infection (2018) (2)
- 775 INSULIN RESISTANCE AND RESPONSE TO THERAPY IN HIV-HCV COINFECTED PATIENTS: HOMAVIC-ANRS HC-02 STUDY (2008) (2)
- [Neuraminidase inhibitors in the general practice management of influenza: who prescribe them, when and with which results?]. (2005) (2)
- Reply to: From the CUPIC study: great times are not coming (?). (2014) (2)
- 791 IMPACT OF ANTIVIRAL TREATMENT ON NON INVASIVE PREDICTORS OF LIVER FIBROSIS IN HIV-HCV CO-INFECTED PATIENTS: THE FIBROVIC 2 STUDY-ANRS HC02 (2008) (2)
- P364 CHARACTERIZATION AND OUTCOME OF ANTIMITOCHONDRIAL TYPE 2-POSITIVE PATIENTS WITHOUT A DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS: A FRENCH NATIONWIDE PROSPECTIVE STUDY (2014) (2)
- Effectiveness of direct‐acting antivirals for chronic hepatitis C treatment in migrant and non‐migrant populations in France (2021) (2)
- Patients With Isolated Hepatitis B Core Antibody: Has the Time Come to Vaccinate? (2018) (2)
- Auto-Immune Origin of B Cells from HCV-Associated Lymphoma (2015) (2)
- Public Health and Economic Impact of Vaccinating Children with a Quadrivalent live Attenuated Influenza Vaccine in France Using a Dynamic Transmission Model. (2014) (2)
- Rapid flu test and neuraminidase inhibitors in healthy adults: a cost-benefit analysis (2001) (2)
- Monitoring the proportion infected by SARS-CoV-2 from age-stratified hospitalisation and serological data (2021) (2)
- 201Thallium (TI) reinjection (RI) after sublingual nitroglycerin administration (S-NGA) could improve sensitivity of rest (R)-redistribution (RD) TI imaging to detect myocardial viability (1995) (2)
- O84 LIVER STIFFNESS ASSESSED BY FIBROSCAN IS A MAJOR PROGNOSTIC FACTOR IN PRIMARY SCLEROSING CHOLANGITIS (2014) (2)
- Sa1118 Withdrawing or Continuing Maintenance Treatment With Thiopurines in Patients With Crohn's Disease in Sustained Clinical Remission: A Lifetime Risk-Benefit Analysis (2015) (2)
- Les inhibiteurs de la neuraminidase dans la grippe en médecine générale : qui prescrit, quand et avec quels résultats ? (2005) (2)
- Effet du traitement par l'acide ursodésoxycholique (AUDC) avec ou sans transplantation hépatique (TH) sur la survie à long terme des malades atteints de cirrhose biliaire primitive (2008) (2)
- Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis (2021) (2)
- Analyse coût-efficacité de la vaccination contre la grippe chez les personnes de 50 à 64 ans en France (2006) (2)
- Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules - A response. (2019) (2)
- Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis (2021) (2)
- Letter: tenofovir may be superior to entecavir for treatment‐naïve chronic hepatitis B patients—authors’ reply (2021) (1)
- P1291 EFFECTIVENESS OF HBV RAPID TESTS IN INVOLVEMENT OF CARE. RESULTS OF A RANDOMIZED, MULTICENTER STUDY (2014) (1)
- HIV and hepatitis C virus co-infection. (2005) (1)
- Quantifying the role of children in influenza spread: an analysis of household follow-up (2004) (1)
- ill patients with pneumonia: a pilot study (2015) (1)
- Determinants of individuals’ risks to 2009 pandemic influenza virus infection at household level amongst Djibouti city residents - A CoPanFlu cross-sectional study (2014) (1)
- Integrating the applicability rate into the performance evaluation of noninvasive staging of liver fibrosis: a step towards a change from the "accuracy" to the "clinical" paradigm. (2011) (1)
- Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in France (2022) (1)
- [Access to social coverage of uninsured patients attending a hospital clinic: a historical cohort study at the Baudelaire outpatient clinic in Paris]. (1998) (1)
- Assessment of a new oral health index in the elderly. A new oral health index (2013) (1)
- Quantifying the burden of influenza: a prospective household contact study in France☆ (2001) (1)
- Re-treatment of chronic HCV infection in HIV co-infected patients and predictors of sustained viral response. (2014) (1)
- IN4 LOWERING THE AGE THRESHOLD FOR ROUTINE INFLUENZA VACCINATION: AN ECONOMIC EVALUATION FOR FOUR EUROPEAN COUNTRIES (2005) (1)
- Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvir (2022) (1)
- [Influenza, influenza-like illness: from theory to practice]. (2014) (1)
- Transesophageal echocardiography for cardiovascular risk estimation in patients with sepsis and new-onset atrial fibrillation: a multicenter prospective pilot study (2021) (1)
- External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis B (2022) (1)
- Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals (2022) (1)
- Is the Alpha Variant of SARS-CoV-2 Associated with a Higher Viral Load than the Historical Strain in Saliva Samples in Patients with Mild to Moderate Symptoms? (2022) (1)
- Trivalent-Inactivated Influenza Vaccine Effectiveness Against Hospitalized Influenza in France During 2014–2015 Winter: Results From the FLUVAC Study (2015) (1)
- articleComparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H 1 N 1 pandemic (2016) (1)
- Social vulnerability of patients co-infected with hepatitis B and hepatitis delta viruses: Data from the ANRS CO22 HEPATHER cohort. (2021) (1)
- Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort (2022) (1)
- International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients (2021) (1)
- Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort (2022) (1)
- Direct, indirect and total effect of HIV coinfection on the risk of non‐liver‐related cancer in hepatitis C virus‐infected patients treated by direct‐acting antivirals: a mediation analysis (2021) (1)
- Body weight, body composition and the risk of SARS‐CoV‐2 infection in a large population‐based sample (2021) (1)
- Cost-effectiveness of scaling-up treatment with nucleoside analogue (NA) for chronic HBV infection: Towards a simplification of recommendations? (ANRS study) (2020) (1)
- 558 Risk factors for bacterial infections in HIV/HCV-coinfected patients during interferon plus ribavirin-based therapy (2006) (1)
- Factors associated with intensity of symptoms in patients seeking medical advice for flu (2004) (1)
- Genetic diversity of genotype 6 HCV infections in France: Epidemiology and consequences for treatment strategy (2019) (1)
- 268-PA10 Projet d'étude épidemiologique de la tuberculose dans l'Est Parisien (1995) (1)
- General practitioners’ management of influenza with or without neuraminidase inhibitors (2007) (1)
- Letter: more studies are needed to elucidate the impact of HBV/HCV coinfection on cirrhosis and its consequences—Authors’ reply (2018) (1)
- Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response. (2022) (1)
- A randomized controlled trial of pegylated-interferon alpha-2B + ribavirin vs interferon alpha-2B + ribavirin in HIV co-infected patients (2003) (1)
- Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among HIV-Negative Participants Using Tenofovir/Emtricitabine-Based Preexposure Prophylaxis in 2020: A Substudy of the French National Agency for Research on AIDS and Viral Hepatitis PREVENIR and Inserm SAPRIS-Sero Cohorts (2022) (1)
- Metabolic Disorders in Patients with Chronic Hepatitis B Virus Infection: Coffee as a Panacea? (ANRS CO22 Hepather Cohort) (2022) (1)
- M-06 Évaluation de la fibrose hépatique (histologie, marqueurs sériques, élastométrie) chez des patients infectés par le VHB au Burkina Faso (2008) (1)
- Survenue de cancers au cours de la sclérodermie systémique : facteurs de risque, impact sur la survie et revue de la littérature (2019) (1)
- Étude transversale des atteintes rénales dans la cohorte de patients infectés par la VHC (HepatherPrévalence) de l’insuffisance rénale chronique (IRC) et facteurs associés chez les patients mono-infectés par le virus de l’hépatite C (VHC) dans la cohorte ANR (2016) (1)
- Survenue de cancer au cours de la sclérodermie systémique : facteurs de risque et impact sur la survie avec revue de la littérature (2018) (1)
- Systèmes d'information pour la sécurité sanitaire : l'exemple de la grippe (2002) (1)
- Impact de l'oseltamivir (Tamiflu®) en prophylaxie antigrippale postexposition sur la mortalité et la morbidité des personnes âgées institutionnalisées (2007) (1)
- Modes de contamination par le virus de l'hépatite C (VHC)chez les personnes non-toxicomanes non transfusées. Résultats de l'étude cas-témoins nationale multicentrique EPIC (2002) (1)
- P20-1 Syndrome frissons-hyperthermie. Étude de l'âge des produits transfusés (1998) (1)
- La grippe : stratégies de vaccination (1994) (1)
- SARS CoV-2 Seroprevalence Among HIV-Negative Participants Using Tenofovir/Emtricitabine Based PrEP in 2020 – A Sub-study of ANRS PREVENIR and INSERM SAPRIS-Sero Cohorts (2022) (1)
- Editorial: similar risk of hepatocellular carcinoma in chronic hepatitis B patients treated with tenofovir or entecavir—new clues from Europe. Authors' reply (2021) (0)
- 297 TREATMENT WITH HYLAN G-F 20 AND CORTIOCSTEROID: EXPECTATIONS OF TREATMENT AND OUTCOMES SIX MONTHS FOLLOWING TREATMENT (2008) (0)
- VaccinationCompartments after Inactivated Influenza Effector and Memory Immune Longitudinal and Integrative Biomodeling of (2013) (0)
- Hepatitis Delta virus in migrants: The challenge of elimination (ANRS CO22 HEPATHER cohort) (2021) (0)
- Predictive models for hepatocellular carcinoma (HCC) occurrence in patients with chronic hepatitis C and sustained virological response (SVR) achieved with direct acting anti-viral (DAA) included in the ANRS CO22 hepather cohort (2020) (0)
- Transmission parameters and real-time estimation methods (2007) (0)
- Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort) (2022) (0)
- HIV co-infection and risk of morbidity and mortality in HCV patients treated by DAA (2020) (0)
- T1310 Almost One Half of Inflammatory Bowel Disease (IBD) Patients at High Risk of Colorectal Neoplasia Do Not Undergo Endoscopic Surveillance: A Clinical Practice Study Nested in the CESAME Cohort (2010) (0)
- Evaluation indépendante et analyse coût/efficacité des marqueurs biologiques non-invasifs de fibrose hépatique chez les patients co-infectés VIH-VHC : étude FIBROVIC-ANRS HC02 (2007) (0)
- Mo1267 Impact of Cytomegalovirus Reactivation Treatment on Inflammatory Bowel Disease Flare (2013) (0)
- C3-4 Le Réseau Sentinelles 1984-2004 : 20 ans d’expérience en France (2004) (0)
- Impact du statut vitaminique D sur la fibrose hépatique chez les patients co-infectés VIH-VHC (2011) (0)
- P1262 : An accurate score for the prediction of sustained viral response under protease inhibitor-based triple therapy in cirrhotic patients: The cupic algorithm – the ANRS CO20 CUPIC study (2015) (0)
- ABO blood types and SARS-CoV-2 infection assessed using seroprevalence data in a large population-based sample: the SAPRIS-SERO multi-cohort study (2023) (0)
- 296 HOW CLINICAL OUTCOMES MAY BE INFLUENCED BY THE NUMBER OF AFFECTED JOINTS IN HAND OA (HOA) (2008) (0)
- Effects of smoking and oral contraceptive use on the clinical course of Crohn's disease (1998) (0)
- Dynamic Personalized Prediction of the Individual Liver-Related Risk after Sustained Viral Response in HCV patients. (2023) (0)
- Kinetics of the SARS-CoV-2 antibody response in immunocompetent convalescent patients: nationwide multicenter 15-month follow-up cohort study (2021) (0)
- Insulin resistance impairs human liver progenitor cell function in vitro: Consequences for liver injury and tumorigenesis in metabolic disease and type 2 diabetes? (2015) (0)
- Heterogeneous SARS-CoV-2 humoral response after COVID-19 vaccination and/or infection in the general population (2022) (0)
- 625 RISK FACTORS FOR HEPATOTOXICITY OF ARV IN HIV/HCV CO-INFECTED PATIENTS WITH A 6 YEARS FOLLOW-UP AFTER A COMPLETION OF A FULL COURSE ANTI-HCV TREATMENT (2009) (0)
- Diversity of circulating HBV genomes and impact on viral infection (2022) (0)
- Histological Characteristics Of Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas. Results Of The French Lympho-C ANRS HC-13 Multicentric Study Of 133 Patients (2013) (0)
- Vaccination against influenza in healthy adults. (1996) (0)
- Cardiometabolic disturbances and hand osteoarthritis: A cross-sectional and longitudinal study (2015) (0)
- RESPIR-08 - Facteurs associés à la gravité d’une grippe confirmée chez des adultes hospitalisés en France de 2012 à 2015 : une étude prospective multicentrique (2016) (0)
- Heterogeneous SARS-CoV-2 humoral response after COVID-19 vaccination and/or infection in the general population (2022) (0)
- OP0053 Inflammatory disorders associated with trisomy 8 myelodysplastic syndromes : french retrospective case control study (2018) (0)
- Quels marqueurs tumoraux doit-on utiliser dans les cancers bronchiques primitifs ? (1997) (0)
- Estimation du titre d’anticorps inhibant l’hémagglutination dans la grippe : approche méthodologique (2011) (0)
- CPC-018 AnETh: An Original Tool For Assessing, Promoting and Improving Your Patient Education (PE) Programme (2013) (0)
- Reply to: "From the CUPIC study: great times are not coming(?)". (2014) (0)
- In-hospital and midterm post-discharge complications of adults hospitalised with respiratory syncytial virus infection in France, 2017–2019: an observational study (2021) (0)
- Performance of algorithms for identifying patients with chronic hepatitis B or C infection in the french health insurance claims databases using the ANRS CO22 HEPATHER cohort (2022) (0)
- Absence of evidence for the efficacy of hydroxychloroquine in systemic sclerosis: data from case-control monocentric study. (2022) (0)
- Les accidents vasculaires cérébraux ischémiques associés à l’artérite à cellules géantes : une étude cas-témoin française (2019) (0)
- Treatment of primary biliary cirrhosis: current standards (2005) (0)
- Estimation de l’excès de décès lié à la grippe (2019) (0)
- Choosing between several diagnostic methods : sensitivity, specificity, predictive valves, probability ratios and roc curves (1998) (0)
- Performance of Marginal Flexible Weighted-Cumulative Exposure models for estimating the time-varying effect of a treatment on clinical outcomes in presence of time-dependent confounding : A simulation study (2018) (0)
- What happens to Kellgren-Lawrence grade 1 joints in hand osteoarthritis (OA) after 2.6 years ? “OA or not OA that is the question ?” - Data from the SEKOIA trial (2014) (0)
- Issue Cover (2020) (0)
- Optimisation de protocole pour l’étude des cinétiques virales dans la grippe (2011) (0)
- Direct‐acting antivirals and the risk of hepatocellular carcinoma: The end of a polemic? (2019) (0)
- ntibody persistence and serological protection among seasonal 2007 nfluenza A ( H 1 N 1 ) infected subjects : Results from the FLUREC cohort tudy osemary (2018) (0)
- SARS-CoV-2 incubation period across variants of concern, individual factors, and circumstances of infection in France: a case series analysis from the ComCor study (2023) (0)
- O76 Syndrome grippal: complications chez les patients diabétiques ou obèses (2015) (0)
- 196 Do hepatic venous flow doppler tracings predict right atrial pressure in patients with hemodynamically-proven right ventricular acute myocardial infarction? (1999) (0)
- Particle filtering for epidemiological surveillance: current activities and perspectives (2009) (0)
- 835 GLOBAL ANALYSIS OF LIVER MIRNAS EXPRESSION IN CHRONIC HEPATITIS C LEADING TO A SIGNATURE TO PREDICT RESPONSE TO TREATMENT (2012) (0)
- P482 Impact of cytomegalovirus reactivation treatment on inflammatory bowel disease flare (2013) (0)
- Efficacité du Tocilizumab dans la COVID-19 modérée à sévère : une cohorte française exposé-non exposé (2021) (0)
- Is the mastectomy flap thickness a good predictor of nipple areolar complex suffering? A radiological study of 73 breasts before nipple sparing mastectomy. (2019) (0)
- CO-02: Syndromes grippaux chez les diabétiques en milieu hospitalier : caractéristiques et complications (2016) (0)
- Publisher Correction: Heterogeneous SARS-CoV-2 humoral response after COVID-19 vaccination and/or infection in the general population (2022) (0)
- Clinical pharmacy and clinical trials (2013) (0)
- Association between positive psychological traits and changes in dietary behaviour related to first COVID-19 lockdown: A general population-based study (2021) (0)
- 942 RADIOLOGIC COURSE OF PRIMARY SCLEROSING CHOLANGITIS (PSC): ASSESSMENT BY MAGNETIC RESONANCE CHOLANGIOGRAPHY (MRC) AND PREDICTIVE FEATURES OF PROGRESSION (2013) (0)
- Publisher Correction: Heterogeneous SARS-CoV-2 humoral response after COVID-19 vaccination and/or infection in the general population (2022) (0)
- PIN72 Burden of Influenza-Related and Associated Hospitalizations in France from Season 2010/11 to 2017/18 (2020) (0)
- Immortal Time and Selection Biases in Study of Direct-Acting Antiviral Treatment and Hepatitis C Outcomes. (2023) (0)
- Contents, Vol. 5, 1990 (1990) (0)
- Comparing interferon‐free with interferon‐based regimens in HCV patients: Rogers phenomenon and Simpson’s paradox (2020) (0)
- Extremes and data assimilation in epidemiology (2008) (0)
- Epidémiologie de la cirrhose biliaire primitive : évaluation de l’incidence de la maladie en France (2010) (0)
- 706 COMPARISON OF LIVER BIOPSY, ELASTOMETRY AND SERUM MARKERS FOR LIVER FIBROSIS ASSESSMENT IN GENOTYPE 4 HCV-INFECTED PATIENTS IN EGYPT. RESULTS OF THE ANRS12184 STUDY (2013) (0)
- Fatty liver index as a risk factor for all-cause and liver related mortality in patients under therapy for chronic hepatitis B (ANRS CO22 Hepather cohort study) (2022) (0)
- SAT-490-No impact of direct-acting antivirals on recurrent hepatocellular carcinoma tumour growth in the ANRS CO22 Hepather Cohort (2019) (0)
- 1429 BASELINE APOLIPOPROTEIN H (ApoH) IS A PREDICTOR OF EARLY VIROLOGIC RESPONSE TO TRIPLE THERAPY (ANRS CO20-CUPIC) (2013) (0)
- The Authors' Reply (2022) (0)
- Factors associated with liver fibrosis in HIV/HCV co-infected patients (2003) (0)
- 762 ADDITIONAL PEG-INTERFERON IN HBeAg-POSITIVE HIV CO-INFECTED PATIENTS ON cART INCLUDING TENOFOVIR: THE ANRS HB01 EMVIPEG STUDY (2013) (0)
- Impact of IL28B, APOH and ITPA Polymorphisms on Ecacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS (2016) (0)
- 25 NON-RANDOM GEOGRAPHIC DISTRIBUTION OF INCIDENT M2 α?TI-MITOCHONDRIAL ANTIBODIES IN FRANCE. ARE ENVIRONMENTAL FACTORS INVOLVED IN THE DEVELOPMENT OF PRIMARY BILIARY CIRRHOSIS? (2011) (0)
- [Quantification of longitudinal myocardial velocities by Doppler tissue imaging during dobutamine echocardiography]. (2004) (0)
- Correction: Impact of Different Oseltamivir Regimens on Treating Influenza A Virus Infection and Resistance Emergence: Insights from a Modelling Study (2014) (0)
- Influenza in patients with diabetes and obesity: vaccine effectiveness against hospitalised influenza and complications after hospitalised influenza-like illness (2015) (0)
- Genetic diversity of genotype 6 HCV infections in France epidemiology and consequences for treatment strategy (2018) (0)
- Corrigendum (2021) (0)
- Sustained virological response to Do hepatitis C DAA treatments in migrants and non-migrants groups (2019) (0)
- Détection d’associations dans un grand jeu de données épidémiologie : une comparaison du data mining, de la régression logistique conventionnelle et de la régression logistique pénalisée pour identifier des facteurs associés à la grippe H1N1 (2014) (0)
- P0794 : Relationship between HCV genotype, liver co-morbidities and fibrosis in the French cohort ANRS CO22 HEPATHER (2015) (0)
- Liver fibrosis and all‐cause mortality in chronic HCV‐infected diabetic patients: A paradoxical association? (ANRS CO22 HEPATHER) (2021) (0)
- Construction of Cohorts of Similar Patients From Automatic Extraction of Medical Concepts: Phenotype Extraction Study (2022) (0)
- P0768 : Late mortality in treatment-experienced cirrhotic patients treated with triple therapy including boceprevir or telaprevir in a real-life cohort - ANRS Co 20 cupic (2015) (0)
- Diversity of the nucleic acid forms of circulating HBV in chronically infected patients and its impact on viral cycle (2022) (0)
- Obstetrical morbidity related to anti-SSA antibodies: Data from a French monocentric retrospective study. (2019) (0)
- Humoral response, associated symptoms and profile of patients infected by SARS-CoV-2 with taste or smell disorders in the SAPRIS multicohort study. (2022) (0)
- Manifestations auto-immunes et inflammatoires associées aux lymphomes : caractéristiques et pronostic d’une série rétrospective de 108 patients (2016) (0)
- CA 64 - ÉVALUATION À 3 ANS DU RISQUE D'HÉPATOPATHIE TERMINALE CHEZ LES MALADES CO-INFECTÉS VIH/VHC APRÈS TRAITEMENT DE L'HÉPATITE CHRONIQUE C (2006) (0)
- Updating mortality risk estimation in intensive care units from high-dimensional electronic health records with incomplete data (2022) (0)
- Efficacité de la vaccination antigrippale saisonnière 2017–2018 chez l’adulte hospitalisé (2018) (0)
- [Influenza vaccine among the aged]. (1995) (0)
- CL4-04 RIBAVIC ANRS HC02: essai thérapeutique évaluant l'efficacité et la tolérance de l'interféron (PEG-IFN α2b versus IFN α2b) en association avec la ribavirine chez les patients porteurs d'une hépatite chronique C non traitée et coinfectés par le VIH (2004) (0)
- Pioglitazone as adjuvant therapy in chronic hepatitis C: Sequential rather than concomitant administration with pegylated interferon and ribavirin? (2009) (0)
- U-01 Modélisation de l’impact de la pré-vaccination sur la pandémie grippale (2009) (0)
- CA36 - Facteurs de risque de la stéatose hépatique chez les malades co-infectés VIH/VHC (2005) (0)
- Vascularites associées aux syndromes myélodysplasiques : étude de cas multicentrique française (2019) (0)
- Utilisation d’un nouvel indice pour évaluer les performances diagnostiques des marqueurs de fibrose non invasifs : l’AUC revisitée (2008) (0)
- ANRS HCO2 - Ribavic : un essai contrôlé randomisé comparant interféron ?-2B pégylé plus ribavirine vs interferon ?-2B plus ribavirine comme traitement initial de l'hépatite chronique C des co-infectés VIH-VHC (2008) (0)
- Évaluation de l’efficacité virologique et de la tolérance du traitement antiviral chez les patients porteurs d’une hépatite C chronique, associée à un lymphome B non hodgkinien : étude cas-témoins ANRS HC13 lympho-C (2014) (0)
- Obturation en voix trachéo-œsophagienne (1999) (0)
- Substantial SF-36 score differences according to the mode of administration of the questionnaire: an ancillary study of the SENTIPAT multicenter randomized controlled trial comparing web-based questionnaire self-completion and telephone interview (2021) (0)
- Efficacité des biothérapies dans les manifestations auto-immunes et systémiques des syndromes myélodysplasiques : étude multicentrique rétrospective de 29 patients (2016) (0)
- C2-1 Modes de contamination par le virus de l’hépatite C chez les personnes non toxicomanes, non transfusées : étude cas-témoins nationale « EPIC » (2004) (0)
- Traitement de l'information epidemiologique dans le temps et dans l'espace. Application a l'etude des donnees de surveillance de la grippe et des syndromes grippaux (1995) (0)
- Évaluation de l’incidence de la cirrhose biliaire primitive en 2007 en France (2008) (0)
- Risques élevés de mitochondriopathie chez les sujets co-infectés VIH/VHC traités par l'association ddI/d4T et interféron (standard ou pégylé)/ribavirine (ANRS HC02-ribavic) (2008) (0)
- Économie, gestion et organisation (2009) (0)
- P0121 : Angiotensin II inhibition to treat severe liver fibrosis: A double-blind randomized trial (ANRS HC19) (2015) (0)
- Caractéristiques des infections à métapneumovirus humain (hMPV) chez des adultes hospitalisés avec un syndrome grippal, France, 2012–2018 (2019) (0)
- L’arthrite au cours de la sarcoïdose aiguë et chronique : caractéristiques et traitement. Étude française rétrospective multicentrique (2019) (0)
- P.235 Early virological response in HIV/HCV co-infected patients to IFN or Peg-IFN plus ribavirin assessed by HCV RNA measurement (2006) (0)
- Grippe, syndrome grippal : de la théorie à la pratique (2014) (0)
- Complications intra-hospitalières et évolution post-hospitalière des infections à virus respiratoire syncytial chez l’adulte (2020) (0)
- PO8 Étude cas-témoin mesurant l’efficacité du vaccin antigrippal saisonnier sur les formes sévères de grippe chez les patients diabétiques ou obèses (2014) (0)
- D1-4 Analyse de la transmission de la grippe dans un suivi longitudinal de foyers (2004) (0)
- CL1-06 Prise en charge de la grippe en médecine générale de ville durant l'épidemie de 2002–2003-cohorte vigitam (2004) (0)
- Morbidité obstétricale associée aux anticorps anti-SSA : données de cohorte rétrospective monocentrique (2020) (0)
- Exploration des impacts respectifs de l’exposition au virus et de la susceptibilité de l’hôte dans l’infection par la grippe pandémique H1N1 par un modèle causal. Résultats d’une cohorte de foyers (2014) (0)
- Décider entre plusieurs méthodes diagnostiques : sensibilité, spécificité, valeurs prédictives, rapport de vraisemblance et courbes ROC (1998) (0)
- [Not Available]. (2016) (0)
- Poids, composition corporelle et risque d’infection par le SARS-CoV-2 au sein d’une large population (2022) (0)
- Manifestations auto-immunes et inflammatoires associées aux syndromes myélodysplasiques avec trisomie 8 : étude cas-contrôles française rétrospective (2018) (0)
- Histoire naturelle d'un virus zoonotique en mode insulaire : cas de la propagation du virus grippal pandémique H1N1p 2009 à La Réunion (2011) (0)
- Tocilizumab au cours du COVID-19 : le plus tôt serait le mieux ? Une analyse exploratoire de cohorte (2021) (0)
- Artérite à cellules géantes associées aux syndromes myélodysplasiques : étude cas contrôle multicentrique française (2019) (0)
- Alimentation et risque d’infection par le SARS-CoV-2 : étude prospective dans la cohorte NutriNet-Santé (2022) (0)
- Absence d’efficacité de l’hydroxychloroquine dans la sclérodermie systémique : données d’une étude cas-témoin monocentrique (2023) (0)
- C09 - Résultats finaux de ribavic (ANRS Hc02) : étude contrôlée randomisée de l’interferon pégylé alfa-2b plus ribavirine vs interferon alfa-2b plus ribavirine chez les co-infectés VIH/VHC (2004) (0)
- Facteurs socio-comportementaux associés à la mortalité de cause hépatique et non hépatique chez les patients atteints d’hépatite C chronique (cohorte ANRS CO22 HEPATHER) (2021) (0)
- Prise en charge de l'infection chronique par le virus de l'hépatite C dans les services de médecine interneet maladies infectieuses en France: Enquête 2001 du GERMIVIC (2002) (0)
- Atteintes cardiaques de la sclérodermie systémique : résultats d’une étude de cohorte nationale française (2022) (0)
- Cinétique et facteurs associés à la réponse humorale de l’infection Cov-19 (2021) (0)
- Traitement de l’infection chronique par le virus de l’hépatite B chez les patients co-infectés ou non par le VIH : étude EPIB-2008 (2010) (0)
- Cinétique et facteurs associés à la réponse humorale de l’infection Cov-19 (2021) (0)
- Prise en charge des hépatites chroniques B en France chez les patients VIH-positifs ou VIH-négatifs, EpiB 2012 (2013) (0)
- P4-12 Estimation de l’efficacité du vaccin anti-grippal en temps réel (2004) (0)
- PAGE-B and FIB-4 predict the occurence of hepatocellular carcinoma in HBV patients: a french nationwide cohort study (2022) (0)
- Estimation du fardeau hospitalier direct et attribuable à la grippe en France à partir de la base PMSI (2020) (0)
- Estimation du fardeau direct et indirect de la grippe en France de la saison 2010/2011 à la saison 2017/2018 : analyse épidémiologique et économique à partir du Programme de médicalisation des systèmes d’information (2020) (0)
- E4-3 - Un modèle « Small world » pour l’évaluation des stratégies de contrôle d’une pandémie grippale (2006) (0)
- PCV60 Cost-Utility of Post-Discharge Educational Interventions in Patients with Acute Coronary Syndrome or Chronic Heart Failure (2012) (0)
- [Comparing two groups of patients]. (2000) (0)
- AB0551 Obstetrical morbidity related to anti-ssa antibodies: data from a french monocentric retrospective study (2018) (0)
- Simultaneous investigation of influenza and enteric viruses in the stools of adult patients consulting in general practice for acute diarrhea (2012) (0)
- ' s response to reviews Title : Age distribution of influenza morbidity and mortality : a comparative analysis between seasonal influenza epidemics and the H 1 N 1 pandemic (2010) (0)
- Effect of indinavir upon body weight of malnourished HIV-infected patients (1998) (0)
- L’insulinorésistance diminue la réponse virologique soutenue au traitement interféron-ribavirine, chez les patients co-infectés VIH–VHC : étude HOMAVIC-ANRS HC02 (2008) (0)
- Effect of maternal and fetal characteristics on diagnosis of intrauterine growth retardation. (1990) (0)
- Early detection of epidermic influenza (1992) (0)
- OP003 Increased risk of acute arterial events in young patients with severely active inflammatory bowel disease: a nationwide French cohort study. (2017) (0)
- 557 Risk factors for anemia in HIV/HCV-coinfected patients during IFN-ribavirin-based therapy (2006) (0)
- Safety and Immunogenicity of Hepatitis B Vaccine Regimens in Adults With HIV-1—Reply (2011) (0)
- Parents’ depression and anxiety associated with hyperactivity-inattention and emotional symptoms in children during school closure due to COVID-19 in France (2023) (0)
- Title Online detection and quantification of epidemics (2007) (0)
- 294 AESTHETIC ASSESSMENT IN HAND OA AND ITS POSSIBLE DETERMINANTS (2008) (0)
- Population Modeling of Influenza A/H1N1 Virus Kinetics and Symptom Dynamics (cid:1) (2011) (0)
- Overall mortality in patients with chronic hepatitis C: major effects of social vulnerability, tobacco smoking, and history of unhealthy alcohol use (ANRS CO22 HEPATHER cohort) (2022) (0)
- Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors (2022) (0)
- Emotional and attention-deficit/hyperactivity disorder symptoms of preterm vs. full-term children during COVID-19 pandemic restrictions (2022) (0)
- Virus-Infected Cirrhotic Patients in Treatment-Experienced Hepatitis C Pegylated Interferon during Triple Therapy Effectiveness of Telaprevir , Boceprevir , and Modeling To Estimate the Antiviral Using Pharmacokinetic and Viral Kinetic (2014) (0)
- Changes in household use of disinfectant and cleaning products during the first lockdown period in France (2022) (0)
- Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors (2022) (0)
- CO.131 Effet des thiopurines sur l’évolution de grossesses chez des patientes souffrant de maladies inflammatoires chroniques de l’intestin (MICI) et suivies dans l’étude CESAME (2009) (0)
- ' s response to reviews Title : Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H 1 N 1 pandemic (2010) (0)
- 796 FACTORS ASSOCIATED WITH SUSTAINED VIROLOGICAL RESPONSE IN HCV/HIV PATIENTS RETREATED WITH PEG-INTERFERON-a2a-360 μg/wk AND RIBAVIRIN HIGH DOSE: RESULTS OF THE ANRS-HC-20 ETOC STUDY (2013) (0)
- P100 Efficacité du vaccin antigrippal saisonnier sur les hospitalisations liées à la grippe chez les patients diabétiques ou obèses (2015) (0)
- Cover Image (2021) (0)
- Iconographies supplémentaires de l'article : Économie, gestion et organisation (2009) (0)
- Respiratory Syncytial Virus Infection in Adults Hospitalized with Influenza-like illness in France. (2016) (0)
- Antibody response, associated symptoms and profile of patients presumably infected by SARS-CoV-2 with taste or smell disorders in the SAPRIS multicohort study (2023) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Fabrice Carrat?
Fabrice Carrat is affiliated with the following schools:
